The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
The anti-inflammatory effects of heparin and related compounds
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Zou, H., Henzel, W. J., Liu, X., Lutschg, A., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80501-2 · Cited by 3,145
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Apoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update
Paparella, D. (2002) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(01)01099-5 · Cited by 969
Lin, Y.-Z., Yao, S., Veach, R. A., Torgerson, T. R., & Hawiger, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14255 · Cited by 918
Bevilacqua, M. P., & Nelson, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116210 · Cited by 877
Heparin protects basic and acidic FGF from inactivation
Gospodarowicz, D., & Cheng, J. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280317 · Cited by 853
Oates, J. A., Wood, A. J. J., & Hirsh, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242206 · Cited by 830
Kubota, T., McTiernan, C. F., Frye, C. S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J., & Feldman, A. M. (1997) · Circulation Research · doi:10.1161/01.res.81.4.627 · Cited by 829
P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin.
Moore, K. L., Patel, K. D., Bruehl, R. E., Li, F., Johnson, D. A., Lichenstein, H. S., Cummings, R. D., Bainton, D. F., & McEver, R. P. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.661 · Cited by 710
The role of neutrophils in myocardial ischemia–reperfusion injury
Jordan, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00187-x · Cited by 646
Signaling Pathways in Reactive Oxygen Species–Induced Cardiomyocyte Apoptosis
von Harsdorf, R., Li, P.-F., & Dietz, R. (1999) · Circulation · doi:10.1161/01.cir.99.22.2934 · Cited by 571
Hirsh, J., Anand, S. S., Halperin, J. L., & Fuster, V. (2001) · Circulation · doi:10.1161/01.cir.103.24.2994 · Cited by 565
Diamond, M. S., Garcia-Aguilar, J., Bickford, J. K., Corbi, A. L., & Springer, T. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.4.1031 · Cited by 533
Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
Nelson, R., Cecconi, O., Roberts, W., Aruffo, A., Linhardt, R., & Bevilacqua, M. (1993) · Blood · doi:10.1182/blood.v82.11.3253.3253 · Cited by 516
(1998) · Elsevier eBooks · doi:10.1016/b978-0-12-186060-8.x5000-1 · Cited by 508
Koenig, A., Norgard-Sumnicht, K., Linhardt, R., & Varki, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1509 · Cited by 403
Irwin, M. W., Mak, S., Mann, D. L., Qu, R., Penninger, J. M., Yan, A., Dawood, F., Wen, W.-H., Shou, Z., & Liu, P. (1999) · Circulation · doi:10.1161/01.cir.99.11.1492 · Cited by 367
Apoptosis: Programmed cell death at a molecular level
Schultz, D. R., & Harringto, W. J. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.50005 · Cited by 356
Gwechenberger, M., Mendoza, L. H., Youker, K. A., Frangogiannis, N. G., Smith, C. W., Michael, L. H., & Entman, M. L. (1999) · Circulation · doi:10.1161/01.cir.99.4.546 · Cited by 342
Extension and structural variability of the antithrombin-binding sequence in heparin.
Lindahl, U., Thunberg, L., Bäckström, G., Riesenfeld, J., Nordling, K., & Björk, I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90755-6 · Cited by 340
Inflammatory roles of P-selectin.
Lorant, D. E., Topham, M. K., Whatley, R. E., McEver, R. P., McIntyre, T. M., Prescott, S. M., & Zimmerman, G. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116623 · Cited by 339
p38 MAPK and NF-κB Collaborate to Induce Interleukin-6 Gene Expression and Release
Craig, R., Larkin, A., Mingo, A. M., Thuerauf, D. J., Andrews, C., McDonough, P. M., & Glembotski, C. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909695199 · Cited by 339
Wang, L., Brown, J. R., Varki, A., & Esko, J. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14996 · Cited by 314
Wang, L., Brown, J. R., Varki, A., & Esko, J. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214996 · Cited by 288
Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).
Diamond, M. S., Alon, R., Parkos, C. A., Quinn, M. T., & Springer, T. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.6.1473 · Cited by 279
Guidelines on the use and monitoring of heparin
Baglin, T., Barrowcliffe, T. W., Cohen, A., Greaves, M., & the British Committee for Standards in Haematology (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05953.x · Cited by 262
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment
Xiang, X. (2005) · Journal of Traumatic Surgery · Cited by 257
The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation
Wulczyn, F. G., Krappmann, D., & Scheidereit, C. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050078 · Cited by 256
Heparin in Inflammation: Potential Therapeutic Applications beyond Anticoagulation
Tyrrell, D. J., Horne, A. P., Holme, K. R., Preuss, J. M. H., & Page, C. P. (1999) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60471-8 · Cited by 245
Heparin and modified heparin inhibit complement activation in vivo
Weiler, J. M., Edens, R. E., Linhardt, R. J., & Kapelanski, D. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3210 · Cited by 220
Preventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled Heparin
Ahmed, T., Garrigo, J., & Danta, I. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307083290204 · Cited by 218
Early activation of transcription factor NF-κB during ischemia in perfused rat heart
Li, C., Browder, W., & Kao, R. L. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.2.h543 · Cited by 207
Chandrasekar, B., Smith, J. B., & Freeman, G. L. (2001) · Circulation · doi:10.1161/01.cir.103.18.2296 · Cited by 200
GMP-140 binding to neutrophils is inhibited by sulfated glycans.
Skinner, M. P., Lucas, C. M., Burns, G. F., Chesterman, C. N., & Berndt, M. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67603-9 · Cited by 197
Paradoxical response to heparin in 10 patients with ulcerative colitis.
Gaffney, P. R., Doyle, C. T., Gaffney, A., Hogan, J., Hayes, D. P., & Annis, P. (1995) · PubMed · Cited by 189
Oxidative Stress Developed During the Reperfusion of Ischemic Myocardium Induces Apoptosis
Maulik, N., Yoshida, T., & Das, D. K. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00388-2 · Cited by 181
Kacimi, R., Karliner, J. S., Koudssi, F., & Long, C. S. (1998) · Circulation Research · doi:10.1161/01.res.82.5.576 · Cited by 163
Yamazaki, T., Seko, Y., Tamatani, T., Miyasaka, M., Yagita∥, H., Okumura, K., Nagai, R., & Yazaki, Y. (1993) · PubMed Central · Cited by 157
Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases
Kang, P. M., & Izumo, S. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00025-x · Cited by 150
Lortat‐Jacob, H., Baltzer, F., & Grimaud, J.-A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16139 · Cited by 146
Aldea, G. S., Doursounian, M., O’Gara, P. J., Treanor, P. R., Shapira, O. M., Lazar, H. L., & Shemin, R. J. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00249-4 · Cited by 139
Diamant, Z., Timmers, M., van der Veen, H., Page, C. P., van der Meer, F. J., & Sterk, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665036 · Cited by 138
Hemorrhage Activates Myocardial NFκB and Increases TNF-α in the Heart
Meldrum, D. R., Shenkar, R., Sheridan, B. C., Cain, B. S., Abraham, E. H., & Harken, A. H. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0506 · Cited by 136
Heparin Inhibits the Immediate Response to Antigen in the Skin and Lungs of Allergic Subjects
Bowler, S., Smith, S. M. S., & Lavercombe, P. S. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.1.160 · Cited by 131
Heparin Inhibits Ligand Binding to the Leukocyte Integrin Mac-1 (CD11b/CD18)
Peter, K., Schwarz, M., Conradt, C., Nordt, T. K., Moser, M., Kübler, W., & Bode, C. (1999) · Circulation · doi:10.1161/01.cir.100.14.1533 · Cited by 126
Unfractioned Heparin in The Therapy of Patients With Highly Active Inflammatory Bowel Disease
Folwaczny, C., Wiebecke, B., & Loeschke, K. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01143.x · Cited by 114
Lever, R., Hoult, J. R. S., & Page, C. P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703099 · Cited by 108
Cain, B. S., Harken, A. H., & Meldrum, D. R. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0924 · Cited by 94
Ang, Y. S., Mahmud, N., White, B., Byrne, M., Kelly, A., Lawler, M., McDonald, G. S. A., Smith, O. P., & Keeling, P. W. N. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00802.x · Cited by 88
Black, S. C., Gralinski, M., Friedrichs, G. S., Kilgore, K. S., Driscoll, E. M., & Lucchesi, B. R. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(96)88632-9 · Cited by 86
Induction of the Acute-Phase Reaction Increases Heparin-Binding Proteins in Plasma
Young, E., Podor, T. J., Venner, T. J., & Hirsh, J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.8.1568 · Cited by 84
Self-citationNonanticoagulant heparin inhibits NF-κB activation and attenuates myocardial reperfusion injury
Thourani, V. H., Brar, S. S., Kennedy, T. P., Thornton, L. R., Watts, J. A., Ronson, R. S., Zhao, Z.-Q., Sturrock, A., Hoidal, J. R., & Vinten‐Johansen, J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h2084 · Cited by 83
Xie, X., Rivier, A.-S., Zakrzewicz, A., Bernimoulin, M. P., Zeng, X., Wessel, H. P., Schapira, M., & Spertini, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001257200 · Cited by 76
Characterization of human platelet GMP-140 as a heparin-binding protein
Skinner, M. P., Fournier, D. J., Andrews, R. K., Gorman, J. J., Chesterman, C. N., & Berndt, M. C. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91821-4 · Cited by 73
Dudás, J., Ramadori, G. P., Knittel, T. E., Neubauer, K., Raddatz, D., Egedi, K., & Kovalszky, I. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500245 · Cited by 72
Guide to Anticoagulant Therapy: Heparin
Hirsh, J., Anand, S. S., Halperin, J. L., & Fuster, V. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0701.093520 · Cited by 69
Elsayed, E. F., & Becker, R. C. (2003) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1026184100030 · Cited by 66
Bloom, S. L., Kiilerich, S., Lassen, M. R., Forbes, A., Leiper, K., Langholz, E., Irvine, E. J., O'Morain, C. A., Lowson, D., & Orm, S. A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01926.x · Cited by 60
Rao, N. V., Kennedy, T. P., Rao, G. V., et al. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.2.407 · Cited by 59
Effect of enoxaparin on high glucose-induced activation of endothelial cells
Mânduțeanu, I., Voinea, M., Antohe, F., Butoi, E. D., Capraru, M., Radulescu, L. M., & Simionescu, M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.016 · Cited by 59
Vrij, A. A., Jansen, J. M., Schoon, E. J., de Bruïne, A. P., Hemker, H. C., & Stockbrügger, R. W. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201753265091 · Cited by 56
Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation
Nissen, N. N., Shankar, R., Gamelli, R. L., Singh, A. K., & DiPietro, L. A. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380637 · Cited by 55
Fritzsche, J., Alban, S., Ludwig, R. J., Rubant, S., Boehncke, W., Schumacher, G., & Bendas, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.05.006 · Cited by 52
Heparin in the treatment of chronic obstructive bronchopulmonary disease
Boyle, J. P., Smart, R. H., & Shirey, J. K. (1964) · The American Journal of Cardiology · doi:10.1016/0002-9149(64)90100-6 · Cited by 46
The effect of complex-formation with polyanions on the redox properties of cytochrome c
Petersen, L. C., & Cox, R. P. (1980) · Biochemical Journal · doi:10.1042/bj1920687 · Cited by 42
P-Selectin-mediated Acute Inflammation Can Be Blocked by Chemically Modified Heparin, RO-Heparin
Gao, Y., Li, N., Fei, R., Chen, Z. H., Zheng, S., & Zeng, X. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)24495-7 · Cited by 39
Role of the β2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion
Lefer, A. M. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)01017-6 · Cited by 38
Huang, L., & Kerns, R. J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.11.013 · Cited by 36
Young, E., Venner, T. J., Ribau, J. C. O., Shaughnessy, S. G., Hirsh, J., & Podor, T. J. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00125-5 · Cited by 35
Self-citationVasoflux, a New Anticoagulant With a Novel Mechanism of Action
Weitz, J. I., Young, E., Johnston, M., Stafford, A. R., Fredenburgh, J. C., & Hirsh, J. (1999) · Circulation · doi:10.1161/01.cir.99.5.682 · Cited by 34
Self-citationGori, A. M., Attanasio, M., Gazzini, A., Rossi, L., Lucarini, L., Miletti, S., Chini, J., Manoni, M., Abbate, R., & Gensini, G. F. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00866.x · Cited by 33
Hecht, I., Hershkoviz, R., Shivtiel, S., Lapidot, T., Cohen, I. R., Lider, O., & Cahalon, L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203659 · Cited by 29
Modulation of acute inflammation by targeting glycosaminoglycan–cytokine interactions
Cripps, J. G., Crespo, F. A., Romanovskis, P., Spatola, A. F., & Fernandez-Botrán, R. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.04.010 · Cited by 28
Akimoto, H., Ito, H., Tanaka, M., Adachi, S., Hata, M., Lin, M., Fujisaki, H., Marumo, F., & Hiroe, M. (1996) · Circulation · doi:10.1161/01.cir.93.4.810 · Cited by 27
Paparella, D., Radi, O. A., Meng, Q. H., Venner, T. J., Teoh, K., & Young, E. (2005) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000172328.58506.4a · Cited by 23
Self-citationPevni, D., Frolkis, I., Shapira, I., Schwartz, D., Yuhas, Y., Schwartz, I. F., Chernichovski, T., & Uretzky, G. (2005) · CHEST Journal · doi:10.1378/chest.128.3.1805 · Cited by 18
Cited by
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection
Pons, S., Fodil, S., Azoulay, E., & Zafrani, L. (2020) · Critical Care · doi:10.1186/s13054-020-03062-7 · Cited by 517
Silva Andrade, B., Siqueira, S., de Assis Soares, W. R., de Souza Rangel, F., Santos, N. O., dos Santos Freitas, A., Ribeiro da Silveira, P., Tiwari, S., Alzahrani, K. J., Góes-Neto, A., et al. (2021) · Viruses · doi:10.3390/v13040700 · Cited by 435
The versatile heparin in COVID-19
Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14821 · Cited by 404
Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
Tersalvi, G., Vicenzi, M., Calabretta, D., Biasco, L., Pedrazzini, G., & Winterton, D. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.009 · Cited by 328
Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles
Salatin, S., & Yari Khosroushahi, A. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13110 · Cited by 315
Metadata
- Authors
- Young, E.
- Venue
- Thrombosis Research
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 122
- Issue
- 6
- Pages
- 743-752
- ISSN
- 0049-3848 (ISSN-L)
- OpenAlex
- W2020613436
- Cited by
- 390
- References
- 79
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.